7. Management of metabolic dysfunction-associated steatotic liver disease (MASLD) in type 2 diabetes

被引：0
作者：
Colagiuri, Stephen [1 ]
Ceriello, Antonio [2 ]
机构：
[1] Univ Sydney, Sydney, Australia
[2] IRCCS MultiMed, Milan, Italy
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2025年 / 222卷
关键词：
CONTROLLED-TRIAL; PIOGLITAZONE; FIBROSIS; PLACEBO;
D O I：
10.1016/j.diabres.2025.112151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：5
相关论文
共 36 条
[11]   Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States [J].
Golabi, Pegah ;
Paik, James M. ;
Kumar, Ameeta ;
Al Shabeeb, Reem ;
Eberly, Kathrine E. ;
Cusi, Kenneth ;
Gundurao, Nagashree ;
Younossi, Zobair M. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 146
[12]   A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis [J].
Harrison, Stephen A. ;
Bedossa, Pierre ;
Guy, Cynthia D. ;
Schattenberg, Joern M. ;
Loomba, Rohit ;
Taub, Rebecca ;
Labriola, Dominic ;
Moussa, Sam E. ;
Neff, Guy W. ;
Rinella, Mary E. ;
Anstee, Quentin M. ;
Abdelmalek, Manal F. ;
Younossi, Zobair ;
Baum, Seth J. ;
Francque, Sven ;
Charlton, Michael R. ;
Newsome, Philip N. ;
Lanthier, Nicolas ;
Schiefke, Ingolf ;
Mangia, Alessandra ;
Pericas, Juan M. ;
Patil, Rashmee ;
Sanyal, Arun J. ;
Noureddin, Mazen ;
Bansal, Meena B. ;
Alkhouri, Naim ;
Castera, Laurent ;
Rudraraju, Madhavi ;
Ratziu, Vlad .
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (06) :497-509
[13]   Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial [J].
Kahl, Sabine ;
Gancheva, Sofiya ;
Strassburger, Klaus ;
Herder, Christian ;
Machann, Juergen ;
Katsuyama, Hisayuki ;
Kabisch, Stefan ;
Henkel, Elena ;
Kopf, Stefan ;
Lagerpusch, Merit ;
Kantartzis, Konstantinos ;
Kupriyanova, Yuliya ;
Markgraf, Daniel ;
van Gemert, Theresa ;
Knebel, Birgit ;
Wolkersdorfer, Martin F. ;
Kuss, Oliver ;
Hwang, Jong-Hee ;
Bornstein, Stefan R. ;
Kasperk, Christian ;
Stefan, Norbert ;
Pfeiffer, Andreas ;
Birkenfeld, Andreas L. ;
Roden, Michael .
DIABETES CARE, 2020, 43 (02) :298-305
[14]   GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease [J].
Kanwal, Fasiha ;
Kramer, Jennifer R. ;
Li, Liang ;
Yang, Yu-Xiao ;
Cao, Yumei ;
Yu, Xian ;
Samuel, Ronald ;
Ali, Basim ;
Desiderio, Roxanne ;
Cholankeril, George ;
Bajaj, Mandeep ;
El-Serag, Hashem B. ;
Asch, Steven M. .
JAMA INTERNAL MEDICINE, 2024, 184 (11) :1314-1323
[15]   The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis [J].
Koutoukidis, Dimitrios A. ;
Koshiaris, Constantinos ;
Henry, John A. ;
Noreik, Michaela ;
Morris, Elizabeth ;
Manoharan, Indrani ;
Tudor, Kate ;
Bodenham, Emma ;
Dunnigan, Anna ;
Jebb, Susan A. ;
Aveyard, Paul .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 115
[16]   Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis [J].
Lee, Yung ;
Doumouras, Aristithes G. ;
Yu, James ;
Brar, Karanbir ;
Banfield, Laura ;
Gmora, Scott ;
Anvari, Mehran ;
Hong, Dennis .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (06) :1040-+
[17]   Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis [J].
Loomba, Rohit ;
Hartman, Mark L. ;
Lawitz, Eric J. ;
Vuppalanchi, Raj ;
Boursier, Jerome ;
Bugianesi, Elisabetta ;
Yoneda, Masato ;
Behling, Cynthia ;
Cummings, Oscar W. ;
Tang, Yuanyuan ;
Brouwers, Bram ;
Robins, Deborah A. ;
Nikooie, Amir ;
Bunck, Mathijs C. ;
Haupt, Axel ;
Sanyal, Arun J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04) :299-310
[18]   Semaglutide 2.4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial [J].
Loomba, Rohit ;
Abdelmalek, Manal F. ;
Armstrong, Matthew J. ;
Jara, Maximilian ;
Kjaer, Mette Skalshoi ;
Krarup, Niels ;
Lawitz, Eric ;
Ratziu, Vlad ;
Sanyal, Arun J. ;
Schattenberg, Jorn M. ;
Newsome, Philip N. .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (06) :511-522
[19]   Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? [J].
Mikolasevic, Ivana ;
Orlic, Lidija ;
Franjic, Neven ;
Hauser, Goran ;
Stimac, Davor ;
Milic, Sandra .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (32) :7236-7251
[20]   Semaglutide 2.4 mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial [J].
Newsome, Philip N. ;
Sanyal, Arun J. ;
Engebretsen, Kristiane A. ;
Kliers, Iris ;
Ostergaard, Laura ;
Vanni, Denise ;
Bugianesi, Elisabetta ;
Rinella, Mary E. ;
Roden, Michael ;
Ratziu, Vlad .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (11-12) :1525-1533
1234